Search

everythinglearnresearchcommunity

for

Search:↓

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Higher antigliadin antibody levels are linked to alopecia areata severity.

The MPV/PC ratio can help assess disease activity in alopecia areata.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Denosumab treatment for osteoporosis can cause hair loss.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

If a child is losing a lot of eyelashes and it keeps happening, doctors should look carefully at their health history because it might be a sign of a different health problem.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Adding PRP to topical mometasone improves and speeds up alopecia areata treatment.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Oral vitamin D treatment can help some children with alopecia areata who have vitamin D deficiency.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.